BridgeBio Pharma (BBIO) Earnings Date & Reports

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

BBIO is expected to report earnings to fall 34.84% to -91 cents per share on April 29

BridgeBio Pharma BBIO Stock Earnings Reports

Q1'25

Est.

$-0.91

Q4'24

Missed

by $0.27

Q3'24

Beat

by $0.13

Q2'24

Beat

by $0.41

Q1'24

Beat

by $0.72

The last earnings report on February 20 showed earnings per share of -139 cents, missing the estimate of -112 cents. With 1.54M shares outstanding, the current market capitalization sits at 6.84B.

View a ticker or compare two or three

Compare

BBIO